Pre-earnings options volume in Vertex is 1.9x normal with puts leading calls 9:4. Implied volatility suggests the market is anticipating a move near 3.7%, or $11.52, after results are released. Median move over the past eight quarters is 4.4%.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VRTX:
- Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports
- Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler
- Vertex Pharmaceuticals initiated with a Hold at Canaccord
- SVB Securities upgrades Vertex to Outperform, raises price target to $374
- Vertex Pharmaceuticals upgraded to Outperform at SVB Securities